LABT vs NIVF (Lakewood-Amedex Biotherapeutics Inc. vs NewGenIvf Group Limited)
Showing Closing Date Range from Sep 24 to Sep 25, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
Before the Regular Session
Current time is 5:04 AM ET. The regular US trading session begins at 9:30 AM ET. Showing closing prices from the prior official trading session.
LABT leads by +9.02% Alpha Spread Today
LABT is trading at -10.55% while NIVF is at -19.57% .
Started At
Official opening auction price
Previous Close
Baseline for today's market open
Gained / Lost Today
Net return against previous session close
Today's Trading Range Position
Where each asset is currently trading relative to its Day Low and Day High
Session Liquidity & Volume
Trading activity, share volume, and estimated dollar liquidity
Session Ledger Comparison
Direct side-by-side breakdown of today's key auction and price metrics
| Metric | LABT | NIVF | Head-to-Head Advantage |
|---|---|---|---|
| Today's Return | -10.55% | -19.57% | LABT +9.02% |
| Net Dollar Move | $-0.21 | $-0.14 | NIVF higher move |
| Open Price | $1.97 | $0.80 | Gap: -1.01% vs 9.59% |
| Day High | $2.00 | $0.86 | Session peaks |
| Day Low | $1.78 | $0.56 | Session troughs |
| Intraday Spread | $0.22 | $0.30 | High/Low spread |
| Share Volume | 109.8K | 792.9K | NIVF more active |
| Est. Dollar Volume | $195.4K | $467.8K | NIVF higher liquidity |
Explore LABT vs NIVF Over Extended Timeframes
Today's session isolates intraday momentum. Switch to normalized multi-day timeframes to analyze historical correlations, cumulative returns, and divergence charts.